Last reviewed · How we verify

Fluticasone Propionate Cream 0.05%

Netherlands Institute for Pigment Disorders · FDA-approved active Small molecule

Fluticasone Propionate Cream 0.05% is a Topical corticosteroid Small molecule drug developed by Netherlands Institute for Pigment Disorders. It is currently FDA-approved for Inflammatory and pruritic dermatoses responsive to topical corticosteroids, Eczema, psoriasis, and other inflammatory skin conditions.

Fluticasone propionate is a topical corticosteroid that suppresses local inflammatory and immune responses in the skin.

Fluticasone propionate is a topical corticosteroid that suppresses local inflammatory and immune responses in the skin. Used for Inflammatory and pruritic dermatoses responsive to topical corticosteroids, Eczema, psoriasis, and other inflammatory skin conditions.

At a glance

Generic nameFluticasone Propionate Cream 0.05%
SponsorNetherlands Institute for Pigment Disorders
Drug classTopical corticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Fluticasone propionate binds to glucocorticoid receptors in skin cells, inhibiting the production of pro-inflammatory cytokines and mediators. This reduces inflammation, itching, and erythema characteristic of inflammatory skin conditions. The 0.05% cream formulation provides moderate potency for localized dermatological use.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluticasone Propionate Cream 0.05%

What is Fluticasone Propionate Cream 0.05%?

Fluticasone Propionate Cream 0.05% is a Topical corticosteroid drug developed by Netherlands Institute for Pigment Disorders, indicated for Inflammatory and pruritic dermatoses responsive to topical corticosteroids, Eczema, psoriasis, and other inflammatory skin conditions.

How does Fluticasone Propionate Cream 0.05% work?

Fluticasone propionate is a topical corticosteroid that suppresses local inflammatory and immune responses in the skin.

What is Fluticasone Propionate Cream 0.05% used for?

Fluticasone Propionate Cream 0.05% is indicated for Inflammatory and pruritic dermatoses responsive to topical corticosteroids, Eczema, psoriasis, and other inflammatory skin conditions.

Who makes Fluticasone Propionate Cream 0.05%?

Fluticasone Propionate Cream 0.05% is developed and marketed by Netherlands Institute for Pigment Disorders (see full Netherlands Institute for Pigment Disorders pipeline at /company/netherlands-institute-for-pigment-disorders).

What drug class is Fluticasone Propionate Cream 0.05% in?

Fluticasone Propionate Cream 0.05% belongs to the Topical corticosteroid class. See all Topical corticosteroid drugs at /class/topical-corticosteroid.

What development phase is Fluticasone Propionate Cream 0.05% in?

Fluticasone Propionate Cream 0.05% is FDA-approved (marketed).

What are the side effects of Fluticasone Propionate Cream 0.05%?

Common side effects of Fluticasone Propionate Cream 0.05% include Skin atrophy, Striae, Telangiectasia, Local irritation or burning, Folliculitis.

What does Fluticasone Propionate Cream 0.05% target?

Fluticasone Propionate Cream 0.05% targets Glucocorticoid receptor and is a Topical corticosteroid.

Related